Texas Children's Hospital
Houston, Texas, 77030, United States
NCT Number: NCT03416712
This will be a randomized control trial of 800 children admitted to the Pediatric Hospital Medicine service at Texas Children's Hospital. Each eligible participant will give informed consent prior to enrollment. Study participants will be randomized into an intervention (400 participants) or control group (400 participants). The intervention group will receive a survey (WE CARE HOUSTON) that has been designed to assess family need for community resources that address the SDH (such as food insecurity, housing insecurity, etc.). The intervention group will receive referrals to community resources based on their responses to the WE CARE HOUSTON survey.
Looking for future studies?
Notify MeUp to 18 year
All sexes
Interventional
Not applicable
Houston, Texas, 77030, United States
This will be a randomized control trial of 800 children admitted to the Pediatric Hospital Medicine service at Texas Children's Hospital. Each eligible participant will give informed consent prior to enrollment.
Study participants will be randomized into an intervention (400 participants) or control group (400 participants). The intervention group will receive a survey (WE CARE HOUSTON) that has been designed to assess family need for community resources that address the SDH (such as food insecurity, housing insecurity, etc.). The intervention group will receive referrals to community resources based on their responses to the WE CARE HOUSTON survey. The intervention group will receive a phone call within 3 months of discharge to ask if they have had trouble following up with resources.
Both the intervention and the control groups will be followed for 6 months. Study investigators will obtain outcome data through structured telephone interviews at 6 months and also through medical record review.
This research has been designed to test our hypotheses:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention group will be completing a survey of social determinants of health and providing resources based on caregiver responses.
Other names: Addressing social needs
Time frame: 6 months after study enrollment
We will assess whether study participants followed up with the resources provided and were able to enroll in needed resources with follow up phone call.
Time frame: 6 months after study enrollment
We will assess whether children in the intervention group will have fewer quantity of all cause emergency department visits, fewer quantity of hospital readmissions on chart review.
Time frame: study enrollment to 6 months after enrollment
We will compare caregiver's baseline and 6 month self-rating of their child's health in categories of "excellent", "good", "fair" or "poor".
Time frame: 6 months after study enrollment
Self report of compliance with vaccinations by parents on follow up survey
Time frame: 6 months after study enrollment
Weight and height will be combined to report BMI in kg/m^2. If height is unavailable, weight will be used and reported in kilograms.
Baylor College of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04211155
Adolescent Behavior, Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT04312945
Adolescent Behavior, Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT04311996
Adolescent Behavior, Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT05471297
Athletic Injuries, Chronic Disease
Ljubljana, Slovenia
View Trial Details